Skip to content
Home/Companies/Healthcare/Wellium

Wellium

Healthcare·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Wellium?

Wellium is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2020.

Hand-verified · updated 2026-04-21

AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorHealthcare

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
BiotechFrance· 2020
ARTHEx Biotech
ARTHEx Biotech
Active
BiotechSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to
Kalsiom
Kalsiom
Active
BiotechFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
BiotechBelgium· 2019
to
SparingVision
SparingVision
Active
BiotechFrance· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Wellium

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Wellium?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Wellium.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue